Uplizna® is an afucosylated IgG1 monoclonal antibody that binds to CD19 and depletes B cells (67), which are involved in the immune response in autoimmune diseases, including neuromyelitis optica spectrum disorder (NMOSD); a rare and severe neurological disease. The gene discussed is CD19; the disease is autoimmune disease.